13F HOLDINGS REPORT
Ally Bridge Group (NY) LLC
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001193125-26-055035
Total Value
$96.0M
Positions
20
Other Managers
1
Confidential Omitted
No
Holdings (20)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | REPLIMUNE GROUP INC | REPL | 1,200,000 | $11.7M | 12.15% |
| 2 | ABIVAX SA | AAVXF | 70,000 | $9.4M | 9.83% |
| 3 | SOLENO THERAPEUTICS INC | SLNO | 168,029 | $7.8M | 8.10% |
| 4 | COMPASS PATHWAYS PLC | CMPS | 1,100,000 | $7.6M | 7.91% |
| 5 | ATAI BECKLEY NV | N0731H103 | 1,713,105 | $7.0M | 7.30% |
| 6 | INVENTIVA SA | IVEVF | 1,500,000 | $7.0M | 7.27% |
| 7 | MINERVA NEUROSCIENCES INC | NERV | 1,655,500 | $6.7M | 6.93% |
| 8 | PRAXIS PRECISION MEDICINES I | PRAX | 19,882 | $5.9M | 6.10% |
| 9 | EDGEWISE THERAPEUTICS INC | EWTX | 225,800 | $5.6M | 5.84% |
| 10 | EDGEWISE THERAPEUTICS INC | EWTX | 195,000 | $4.8M | 5.04% |
| 11 | EUPRAXIA PHARMACEUTICALS INC | EPRX | 397,895 | $3.0M | 3.13% |
| 12 | OVID THERAPEUTICS INC | OVID | 1,785,000 | $2.9M | 3.03% |
| 13 | TAYSHA GENE THERAPIES INC | TSHA | 500,000 | $2.8M | 2.86% |
| 14 | TAYSHA GENE THERAPIES INC | TSHA | 457,132 | $2.5M | 2.62% |
| 15 | UNIQURE NV | QURE | 100,000 | $2.4M | 2.49% |
| 16 | UNIQURE NV | QURE | 100,000 | $2.4M | 2.49% |
| 17 | SOLID BIOSCIENCES INC | SLDB | 413,625 | $2.3M | 2.43% |
| 18 | WHITEHAWK THERAPEUTICS INC | WHWK | 817,939 | $2.0M | 2.06% |
| 19 | PROMIS NEUROSCIENCES INC | PMN | 249,339 | $1.7M | 1.77% |
| 20 | EDGEWISE THERAPEUTICS INC | EWTX | 24,200 | $600,523 | 0.63% |